# X4 Pharmaceuticals, Inc: Form 8-K, filed Aug 12, 2025

- Company: [X4 Pharmaceuticals, Inc](/companies/xfor.md) (CIK 1501697)
- Form: 8-K
- Filed: 2025-08-12
- Accepted by EDGAR: Aug 12, 2025, 08:25 ET
- Period: 2025-08-11
- Accession: 0001628280-25-039770
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1501697/000162828025039770/xfor-20250811.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1501697/000162828025039770/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 3.02: Unregistered sale of equity
- Item 5.02: Departure or appointment of officers or directors
- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1501697/000162828025039770/xfor-20250811.htm

Filed Aug 12, 2025.
Source: SEC EDGAR, the filing index for accession 0001628280-25-039770. Last ingested by Listed: Oct 29, 2026, 10:01 ET. No prices; not investment advice.